UBS Lux Equity Fund Biotech USD vs TIN Ny Teknik

UBS Lux Equity Fund Biotech USD vs TIN Ny Teknik

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. TIN Ny Teknik

  • Security

    TIN Ny Teknik A

  • Fee

    1.50%

  • ISIN

    SE0012193019

  • Holdings

    10

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with TIN Ny Teknik, we have 10 holdings where Surgical Science is the largest holding (7.39), followed by Novo Nordisk (5.98) and ChemoMetec (5.92).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and TIN Ny Teknik.

UBS Lux Equity Fund Biotech USD TIN Ny Teknik
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Surgical Science Sweden AB
Sweden
7.39 %
2. Moderna Inc
9.21 %
2. Novo Nordisk B
Denmark
5.98 %
3. Gilead Sciences Inc
USA
4.66 %
3. ChemoMetec
Denmark
5.92 %
4. BioNTech SE
4.13 %
4. Paradox Interactive AB
Sweden
5.85 %
5. Karuna Therapeutics Inc
3.75 %
5. Qt Group Plc
Finland
5.12 %
- 6. Epidemic Sound Holdings AB
Sweden
5.11 %
- 7. BioGaia B
Sweden
5.06 %
- 8. Fortnox AB
Sweden
5.02 %
- 9. Evolution Gaming Group AB
Sweden
4.6 %
- 10. Sectra B
Sweden
4.45 %

The list of fund holdings was last updated on September 10, 2025.